Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives

Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives

Cefiderocol is a new cephalosporin displaying against extensively resistant (XDR) Gram-negative bacteria. We report our experience with cefiderocol-based combination therapies as “rescue” treatments in immunocompromised or critically ill patients or in patients with post-surgical infections who had...

Full description

Bibliographic Details
Main Authors: Davide Fiore Bavaro, Alessandra Belati, Lucia Diella, Monica Stufano, Federica Romanelli, Luca Scalone, Stefania Stolfa, Luigi Ronga, Leonarda Maurmo, Maria Dell’Aera, Adriana Mosca, Lidia Dalfino, Salvatore Grasso, Annalisa Saracino
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Antibiotics
Subjects:
cefiderocol
multidrug resistant gram-negative bacteria
novel antimicrobial strategies
<i>Pseudomonas aeruginosa</i>
<i>Acinetobacter baumannii</i>
<i>Klebsiella pneumoniae</i>
Online Access:https://www.mdpi.com/2079-6382/10/6/652

Internet

https://www.mdpi.com/2079-6382/10/6/652

Similar Items